Sun, December 22, 2024
AUS Edition NZ Edition UK Edition CA Edition USA Edition FRA Edition GER Edition ESP Edition ITA Edition NLD Edition
PRT Edition SWE Edition GRC Edition IND Edition POL Edition BRA Edition ZAF Edition RUS Edition CHN Edition UAE Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. IDOGEN
Healthcare
Facebook Twitter Linkedin

Idogen AB (SS:IDOGEN)

0.1205 SEK

0.000 0.000%
Last Updated at: 2024-12-18T08:00:00Z

Idogen AB

Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden.

Medicon Village, Lund, Sweden, 223 81

46 4 62 75 63 30

https://www.idogen.com

Employees: 6

Key Executives

Sr. No. Name Title Year Born
1. Dr. Christina Herder Ph.D. Acting CEO & Director 1961
2. Prof. Leif G. Salford M.D., Ph.D. Founder & Chairman of the Scientific Advisory Board 1941
3. Mr. Ingvar Karlsson Chief Financial Officer 1956
4. Mr. Dennis B. Henriksen M.Sc., Ph.D. Chief Technology Officer 1962
5. Ms. Hanjing Xie Chief Medical Officer 1970
6. Mr. Rory Graham Chief Regulatory Officer NA

No data found

Income Statement

(Currency in SEK)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Income Before Tax -47.111M -38.854M -26.822M -32.694M -27.634M
Minority Interest - - - - -
Net Income -47.608M -38.856M -26.823M -32.695M -27.634M
Selling General Administrative 34.857M 38.828M 21.007M 17.901M 21.488M
Gross Profit - - - - -
Reconciled Depreciation 0.997M 1.418M 1.325M 5.895M 0.991M
Ebit -47.972M -38.965M -26.153M -32.826M -27.634M
Ebitda -46.255M -37.434M -25.496M -26.798M -26.643M
Depreciation And Amortization 1.717M 1.531M 0.657M 6.029M 0.991M
Operating Income -47.972M -38.965M -26.153M -32.826M -27.861M
Other Operating Expenses 47.474M 38.964M 26.153M 32.826M 27.861M
Interest Expense 0.001M 0.002M 0.001M 0.001M 0M
Tax Provision 0M 0M 0M 0M 0M
Interest Income - - - - 0M
Net Interest Income -0.001M -0.002M -0.001M -0.001M -0M
Income Tax Expense 0.497M 0.002M 0.001M 0.001M 0.227M
Total Revenue 0M 0M 0M 0M 0M
Total Operating Expenses 47.474M 38.964M 26.153M 32.826M 27.861M
Cost Of Revenue - - - - -
Total Other Income Expense Net 0.861M 0.111M -0.669M 0.132M 0.227M
Net Income From Continuing Ops -47.111M -38.854M -26.822M -32.694M -27.634M
Net Income Applicable To Common Shares -47.75M -38.854M -26.822M -32.694M -27.634M

Balance Sheet

(Currency in SEK)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Total Assets 8.996M 23.069M 50.843M 31.189M 71.674M
Intangible Assets 0.001M - - - 4.06M
Other Current Assets - 0.001M 1.682M -0M 1.353M
Total Liab 5.384M 12.082M 10.222M 12.86M 20.651M
Total Stockholder Equity 3.612M 10.987M 40.621M 18.329M 51.023M
Other Current Liab 3.279M 10.159M 8.634M 10.677M 13.484M
Common Stock 5.102M 16.149M 12.77M 3.394M 3.394M
Capital Stock 5.102M 16.149M 12.77M 3.394M 3.394M
Retained Earnings -47.75M -87.57M -48.716M -21.894M 7.882M
Good Will - - - - -
Other Assets - -0.001M 0.001M 0M 0M
Cash 5.304M 15.56M 47.041M 26.008M 61.605M
Cash And Equivalents - - - - -
Total Current Liabilities 5.384M 12.083M 10.222M 12.86M 20.651M
Current Deferred Revenue - - - - -
Net Debt -5.304M -15.56M -47.041M -26.008M -61.605M
Short Term Debt - - - - -
Short Long Term Debt - - - - -
Short Long Term Debt Total - - - - -
Other Stockholder Equity 46.26M 82.408M 76.567M 36.829M 39.747M
Property Plant Equipment - 1.211M 2.119M 3.444M 4.656M
Total Current Assets 8.995M 21.858M 48.723M 27.745M 62.957M
Long Term Investments - - - - -
Short Term Investments - - - - -
Net Receivables 2.674M 1.266M 0.975M 0.867M 0.706M
Long Term Debt - - - - -
Inventory - - - - -
Accounts Payable 2.105M 1.924M 1.588M 2.184M 7.167M
Accumulated Other Comprehensive Income - - - - -
Non Currrent Assets Other - - -0.001M - 0M
Non Current Assets Total 0.001M 1.211M 2.119M 3.444M 8.716M
Capital Lease Obligations - - - - -
Long Term Debt Total - - - - -

Cash Flow

(Currency in SEK)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Investments 0.071M -0.51M -0.001M -0.623M -3.714M
Total Cashflows From Investing Activities 0.071M -0.51M -0.51M -0.623M -3.714M
Total Cash From Financing Activities 40.375M 9.22M 49.115M 49.115M 38.769M
Net Income -47.75M -38.855M -26.823M -32.694M -27.634M
Change In Cash -10.256M -31.481M 21.033M -35.597M 24.661M
Begin Period Cash Flow 15.56M 47.041M 26.008M 61.605M 36.943M
End Period Cash Flow 5.304M 15.56M 47.041M 26.008M 61.605M
Total Cash From Operating Activities -50.703M -40.19M -28.081M -34.975M -10.393M
Depreciation 0.997M 1.418M 1.325M 5.895M 0.991M
Other Cashflows From Investing Activities - - - - -
Dividends Paid - - - - -
Change To Inventory - - - - -
Sale Purchase Of Stock - - - - -
Other Cashflows From Financing Activities 0.071M -0.51M -10.866M -0.623M -3.714M
Capital Expenditures 1.64M 0.51M 0.51M 0.623M 3.714M
Change In Working Capital -4.091M -2.754M -2.583M -8.175M 16.25M
Other Non Cash Items 0.141M 0.001M -0.001M - -
Free Cash Flow -52.343M -40.7M -28.081M -35.597M -14.107M

No data found

Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
Open in the App